These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2793379

  • 1. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    McGuire WP, Blessing JA, Yordan E, Beecham J.
    Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
    McGuire WP, Blessing JA, Berman ML.
    Invest New Drugs; 1989 Nov; 7(4):333-6. PubMed ID: 2557300
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma.
    Frustaci S, Gasparini G, Veronesi A, Tirelli U, Pacciarini MA, Crivellari D, Zagonel V, Monfardini S.
    Invest New Drugs; 1987 Nov; 5(3):307-9. PubMed ID: 3667167
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.
    McGuire WP, Blessing JA, Hatch KD, Berman ML.
    Invest New Drugs; 1990 May; 8(2):195-7. PubMed ID: 2384306
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix.
    Asbury RF, Blessing JA, Soper JT.
    Am J Clin Oncol; 1994 Apr; 17(2):125-8. PubMed ID: 8141104
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB, Blessing JA, Eddy GL, McGehee R.
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, Barnes W, Ball H.
    Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
    [Abstract] [Full Text] [Related]

  • 12. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG, Blessing JA, Arseneau J.
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH, Blessing JA, Homesley HD, Hanjani P.
    Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB, Blessing JA, Malfetano J.
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J.
    Cancer; 1981 Aug 15; 48(4):899-903. PubMed ID: 7196794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.